DMII Issues $150,000 Bridge Note to Alpha Multi Family Office Under Larger Financing Plan
Drugs Made In America Acquisition II Corp. issued a $150,000 unsecured convertible bridge note to Alpha Multi Family Office on March 11, 2026, as the first payment toward a contemplated $1,400,000 convertible notes financing. The company intends to use the bridge proceeds for accounting, audit and other expenses related to its business combination, and the rest of the financing remains subject to a definitive agreement not yet signed.
Key points
- Bridge note: $150,000 principal, no interest, maturity nine months from issuance, convertible at a 35% discount to market after a business combination
- Total contemplated financing: $1,400,000, with $1,250,000 still subject to a convertible note purchase agreement yet to be negotiated
- Addendum dated March 9, 2026 contemplates $400,000 in aggregate funding disbursed on or prior to March 30, 2026
The filing
Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 17, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.